(Q46227426)

English

Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

scientific article published in February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

1 reference

based on heuristic

inferred from title

fatty liver disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

author name string

Engin Ulukaya

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

Enver Dolar

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

language of work or name

0 references

publication date

1 February 2009

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

49

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

697; author reply 697

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22691

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22691

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22691

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22691

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.22691

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19035337

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46227426&oldid=2100503508"